Patient-Derived Xenograft Mouse Model of a Rare Gynecologic Malignancy: Personalized Medicine for the Treatment of Mesonephric-Like Adenocarcinoma.
Saved in:
| Title: | Patient-Derived Xenograft Mouse Model of a Rare Gynecologic Malignancy: Personalized Medicine for the Treatment of Mesonephric-Like Adenocarcinoma. |
|---|---|
| Authors: | Kasuya K; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Kinose Y; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Wang Y; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Koizumi M; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Shimizu A; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Kawano M; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Kodama M; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Kobayashi E; Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Yufu City, JPN., Sawada K; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN., Kimura T; Department of Obstetrics and Gynecology, the University of Osaka Graduate School of Medicine, Suita City, JPN. |
| Source: | Cureus [Cureus] 2025 Oct 27; Vol. 17 (10), pp. e95530. Date of Electronic Publication: 2025 Oct 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
